ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹114 Cr | ₹106 Cr | ₹97 Cr | ₹87 Cr | ₹121 Cr |
What is the latest Contingent Liabilities ratio of ABBOTT INDIA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹114 Cr |
| Mar2025 | ₹106 Cr |
| Mar2024 | ₹97 Cr |
| Mar2023 | ₹87 Cr |
| Mar2022 | ₹121 Cr |
How is Contingent Liabilities of ABBOTT INDIA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹114 Cr | 7.46 | |
| Mar2025 | ₹106 Cr | 10.00 | |
| Mar2024 | ₹97 Cr | 10.44 | |
| Mar2023 | ₹87 Cr | -28.00 | |
| Mar2022 | ₹121 Cr | - | |
Compare Contingent Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹56,884.1 Cr | -0.4% | 2.7% | -10.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | -0.4% |
2.7% |
-10.1% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses